Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Ureaplasma urealyticum risk factors

Introduction

Overview

Overview

Risk factors that have been identified for Ureaplasma colonization/infection include factors such as heavy urogenital colonization in adults, multiple sexual partners, immunosuppression, and prematurity in neonates.[1][2][3][4][5][6]

Risk factors

Risk factors

Risk factors for Ureaplasma infection in infants include the following:[1][2][3][4][5][6]

Neonatal factors

Maternal factors

Risk factors for Ureaplasma colonization/infection in adult men and women:[7][8][9][10][11][12]

References

References

  1. ↑ 1.0 1.1 Waites KB, Crouse DT, Cassell GH (1993). “Systemic neonatal infection due to Ureaplasma urealyticum”. Clin Infect Dis. 17 Suppl 1: S131–5. PMID 8399903.
  2. ↑ 2.0 2.1 Resch B, Gutmann C, Reiterer F, Luxner J, Urlesberger B (2016). “Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics”. Infection. 44 (3): 323–7. doi:10.1007/s15010-015-0858-7. PMID 26518581.
  3. ↑ 3.0 3.1 Viscardi RM, Hashmi N, Gross GW, Sun CC, Rodriguez A, Fairchild KD (2008). “Incidence of invasive ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage”. J Perinatol. 28 (11): 759–65. doi:10.1038/jp.2008.98. PMC 5334544. PMID 18596706.
  4. ↑ 4.0 4.1 Harada K, Tanaka H, Komori S, Tsuji Y, Nagata K, Tsutsui H; et al. (2008). “Vaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses”. Microbiol Immunol. 52 (6): 297–304. doi:10.1111/j.1348-0421.2008.00039.x. PMID 18577163.
  5. ↑ 5.0 5.1 Kikhney J, von Schöning D, Steding I, Schulze J, Petrich A, Hiergeist A; et al. (2017). “Is Ureaplasma spp. the leading causative agent of acute chorioamnionitis in women with preterm birth?”. Clin Microbiol Infect. 23 (2): 119.e1–119.e7. doi:10.1016/j.cmi.2016.10.010. PMID 27756710.
  6. ↑ 6.0 6.1 KouckĂ˝ M, MalĂ­ÄŤková K, Cindrová-Davies T, Smíšek J, VráblĂ­ková H, ÄŚernĂ˝ A; et al. (2016). “Prolonged progesterone administration is associated with less frequent cervicovaginal colonization by Ureaplasma urealyticum during pregnancy – Results of a pilot study”. J Reprod Immunol. 116: 35–41. doi:10.1016/j.jri.2016.04.285. PMID 27172838.
  7. ↑ Marovt M, Keše D, Kotar T, Kmet N, Miljković J, Ĺ oba B; et al. (2015). “Ureaplasma parvum and Ureaplasma urealyticum detected with the same frequency among women with and without symptoms of urogenital tract infection”. Eur J Clin Microbiol Infect Dis. 34 (6): 1237–45. doi:10.1007/s10096-015-2351-8. PMID 25717022.
  8. ↑ Povlsen K, Bjørnelius E, Lidbrink P, Lind I (2002). “Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis”. Eur J Clin Microbiol Infect Dis. 21 (2): 97–101. PMID 11939406.
  9. ↑ Maeda S, Deguchi T, Ishiko H, Matsumoto T, Naito S, Kumon H; et al. (2004). “Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization”. Int J Urol. 11 (9): 750–4. doi:10.1111/j.1442-2042.2004.00887.x. PMID 15379939.
  10. ↑ Couldwell DL, Gidding HF, Freedman EV, McKechnie ML, Biggs K, Sintchenko V; et al. (2010). “Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men”. Int J STD AIDS. 21 (5): 337–41. doi:10.1258/ijsa.2009.009499. PMID 20498103.
  11. ↑ Benedetto C, Tibaldi C, Marozio L, Marini S, Masuelli G, Pelissetto S; et al. (2004). “Cervicovaginal infections during pregnancy: epidemiological and microbiological aspects”. J Matern Fetal Neonatal Med. 16 Suppl 2: 9–12. doi:10.1080/14767050410001727107. PMID 15590426.
  12. ↑ George MD, Cardenas AM, Birnbaum BK, Gluckman SJ (2015). “Ureaplasma septic arthritis in an immunosuppressed patient with juvenile idiopathic arthritis”. J Clin Rheumatol. 21 (4): 221–4. doi:10.1097/RHU.0000000000000248. PMID 26010188.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]